edoxaban
Showing 201 - 208 of 208
WATCHMAN for Second Prevention of Stroke (WASPS)
Unknown status
- Atrial Fibrillation
- Stroke
- WATCHMAN transplantation
- Oral anticoagulant drugs
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Oct 26, 2017
Atherosclerosis in Atrial Fibrillation
Unknown status
- Atrial Fibrillation
- +4 more
-
Rome, ItalyUmberto I Policlinico di Roma, Sapienza Università di Roma
Feb 20, 2018
Atrial Fibrillation, Deep Venous Thrombosis Trial in China (Genotype-guided dosing algorithm for warfarin, Standard initiation
Completed
- Atrial Fibrillation
- Deep Venous Thrombosis
- Genotype-guided dosing algorithm for warfarin
- Standard initiation dose for warfarin
-
Changsha, Hunan, China
- +14 more
Nov 1, 2017
Atrial Fibrillation Trial in Bucheon (left atrial appendage occlusion, New oral anticoagulants)
Unknown status
- Atrial Fibrillation
- left atrial appendage occlusion
- New oral anticoagulants
-
Bucheon, Gyeonggi, Korea, Republic ofSejong general hospital, 91-121 Sosa 2-Dong, Sosa-Gu
May 23, 2017
Ischemic Stroke, Atrial Fibrillation Symptomatic Trial in Kawasaki, Sagamihara, Yokohama
Unknown status
- Ischemic Stroke
- Atrial Fibrillation Symptomatic
-
Kawasaki, Kanagawa, Japan
- +2 more
Oct 18, 2016
Edoxaban on Coagulability and Thrombin Generation: An in Vitro
Unknown status
- Heart Failure
- Edoxaban
-
Baltimore, MarylandSinai Center for Thrombosis Research
May 15, 2015
Atrial Fibrillation Trial in Tainan, Dou-Liou City, Kaohsiung (Dabigatran etexilate, Rivaroxaban, Apixaban)
Unknown status
- Atrial Fibrillation
- Dabigatran etexilate
- +2 more
-
Tainan, Tainan City, Taiwan
- +4 more
Feb 14, 2016
